We implemented a double-blind between-subject design where @ healthy female volunteers received a single dose of the selective serotonin reuptake inhibitor ( SSRI ) citalopram ( @ mg ) , while @ control subjects ( matched on age , intelligence , and years of education ) received a placebo .